Inventor · disambiguated record
Haruhide Kimura
Also filed as: KIMURA HARUHIDE
8 granted patents·5 pending applications·15 citations·filing 2001–2025
78Inventor score
Files withKIMURA HARUHIDE4TAKEDA PHARMACEUTICAL4TAKEDA PHARMACEUTICALS CO2TAKEDA CHEMICAL INDUSTRIES LTD1TAKEDA PHARMACEUTICAL LTD COMPANY1
Top patents by PatentIndex Score
13 records- 0183US7767665B21,3-benzothiazinone derivatives and use thereofTAKEDA PHARMACEUTICAL·Filed 2008·Granted Aug 3, 2010·7 cites·17 claims
- 0269US7399759B21, 3-benzothiazinone derivatives and use thereofTAKEDA PHARMACEUTICAL·Filed 2002·Granted Jul 15, 2008·4 cites·11 claims
- 0367US6794383B2Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseasesTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2001·Granted Sep 21, 2004·4 cites·16 claims
- 0456US2008160553A1Method of preparing heart muscle cells and method of searching for remedy for heart diseasesTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 0554US8173360B2Cell death inhibitorKIMURA HARUHIDE·Filed 2009·Granted May 8, 2012·0 cites·3 claims
- 0652US2024165092A1Use of an orexin 2 receptor agonist for post operation recoveryTAKEDA PHARMACEUTICAL LTD COMPANY·Filed 2022·Application pending·0 cites
- 0745US8450070B2Method for screening of cell-protecting agentKIMURA HARUHIDE·Filed 2008·Granted May 28, 2013·0 cites·5 claims
- 0844US7659267B21,3-Benzothiazinone derivatives, process for producing the same use thereofTAKEDA PHARMACEUTICAL·Filed 2003·Granted Feb 9, 2010·0 cites·11 claims
- 0944US2006034832A1Cell death inhibitorKIMURA HARUHIDE·Filed 2003·Application pending·0 cites
- 1043US2025375417A1Orexin receptor 2 (ox2r) agonist for use in narcolepsy type 1 (nt1)TAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 1142US9044483B2Cell death inhibition by macrophage migration inhibitory factor and a binding substance theretoKIMURA HARUHIDE·Filed 2007·Granted Jun 2, 2015·0 cites·6 claims
- 1242US2003175847A1Method of preparing heart muscle cells and method of searching for remedy for heart diseasesFiled 2001·Application pending·0 cites
- 1335US12298319B2Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 13, 2025·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →